20 LATEST RESOURCES (745 INDEXED)
×
A Prospective Cohort Study on the Intergenerational Transmission of Childhood Adversity and Subsequent Risk of Psychotic Experiences in Adolescence · December 2022
Articles
Schizophrenia Bulletin
×
Childhood Trauma as a Mediator of the Association Between Autistic Traits and Psychotic Experiences: Evidence from the Avon Longitudinal Study of Parents and Children Cohort · November 2022
Articles
Schizophrenia Bulletin
×
Dynamic Interactive Social Cognition Training in Virtual Reality (DiSCoVR) versus Virtual Reality Relaxation (VRelax) for People with a Psychotic Disorder: A Single-Blind Multicenter Randomized Controlled Trial · November 2022
Articles
Schizophrenia Bulletin
×
Auditory Hallucinations and Self-Injurious Behavior in General Population Adolescents: Modeling Within-Person Effects in the Tokyo Teen Cohort · November 2022
Articles
Schizophrenia Bulletin
×
Reduction in Multiple Cardiometabolic Risk Factors with Combined Olanzapine/Samidorphan Compared with Olanzapine: Post Hoc Analyses from a 24-Week Phase 3 Study · October 2022
Articles
Schizophrenia Bulletin
×
First-Episode Psychosis Patients Who Deteriorated in the Premorbid Period Do Not Have Higher Polygenic Risk Scores than Others: A Cluster Analysis of EU-GEI Data · August 2022
Articles
Schizophrenia Bulletin
×
N-Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms · July 2022
Articles
Schizophrenia Bulletin
×
Increased Belief Instability in Psychotic Disorders Predicts Treatment Response to Metacognitive Training · May 2022
Articles
Schizophrenia Bulletin
×
Improving the Applicability of AI for Psychiatric Applications through Human-in-the-Loop Methodologies · May 2022
Articles
Schizophrenia Bulletin
×
Probiotics Plus Dietary Fiber Supplements Attenuate Olanzapine-Induced Weight Gain in Drug-Naive First-Episode Schizophrenia Patients: Two Randomized Clinical Trials · May 2022
Articles
Schizophrenia Bulletin
×
Optimal Doses of Specific Antipsychotics for Relapse Prevention in a Nationwide Cohort of Patients with Schizophrenia · May 2022
Articles
Schizophrenia Bulletin
×
The Time is Ripe for a Consensus Definition of Clinical Recovery in First-Episode Psychosis: Suggestions Based on a 10-Year Follow-Up Study · April 2022
Articles
Schizophrenia Bulletin
×
Brain-Heart Link in Schizophrenia: Cognitive Inhibitory Control Deficit in Patients Is Specifically Related to Parasympathetic Dysregulation · March 2022
Articles
Schizophrenia Bulletin
×
Application of a Machine Learning Algorithm for Structural Brain Images in Chronic Schizophrenia to Earlier Clinical Stages of Psychosis and Autism Spectrum Disorder: A Multiprotocol Imaging Dataset Study · March 2022
Articles
Schizophrenia Bulletin
×
Primary Nonadherence to Antipsychotic Treatment among Persons with Schizophrenia · March 2022
Articles
Schizophrenia Bulletin
×
Efficacy and Safety of Roluperidone for the Treatment of Negative Symptoms of Schizophrenia · February 2022
Articles
Schizophrenia Bulletin
×
Childhood Maltreatment, Educational Attainment, and IQ: Findings from a Multicentric Case-Control Study of First-Episode Psychosis (EU-GEI) · February 2022
Articles
Schizophrenia Bulletin
×
Antipsychotic-Induced Weight Gain: Dose-Response Meta-Analysis of Randomized Controlled Trials · February 2022
Articles
Schizophrenia Bulletin
×
Machine Learning Identifies Digital Phenotyping Measures Most Relevant to Negative Symptoms in Psychotic Disorders: Implications for Clinical Trials · December 2021
Articles
Schizophrenia Bulletin
×
Trait Anhedonia in Schizophrenia: A Systematic Review and Comparative Meta-Analysis · December 2021
Articles
Schizophrenia Bulletin